Patent ID: 11957684
Assignee: SUMITOMO PHARMA SWITZERLAND GMBH
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 18:
19. The method of claim 1, wherein the treatment causes at least three results selected from the group consisting of:
(i) the woman's daily serum estradiol concentration is between 20 pg/ml and 50 pg/ml between daily doses of the single dosage form;
(ii) the woman does not experience vasomotor symptoms during the treatment;
(iii) the woman's bone mineral density during treatment is within +/−3% of the woman's baseline bone mineral density prior to treatment;
(iv) one or both of the number or size of the woman's uterine fibroids are reduced after beginning treatment compared to one or both of the woman's baseline number and size of the uterine fibroids prior to treatment;
(v) the woman experiences a reduction in pelvic pain after beginning treatment compared to the woman's baseline before treatment; and
(vi) the woman experiences amenorrhea after beginning treatment.